Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 February 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 220 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 6 results:
Author Title [ Type(Desc)] Year
Filters: Author is van den Ham, H. A.  [Clear All Filters]
Journal Article
R. F. Gulluoglu, Souverein, P. C., van den Ham, H. A., de Boer, A., and Komen, J., Comparative effectiveness and safety of direct oral anticoagulants versus warfarin in UK patients with atrial fibrillation and type 2 diabetes: A retrospective cohort study, Pharmacoepidemiol Drug Saf, 2020.
H. A. van den Ham, Klungel, O. H., Singer, D. E., Leufkens, H. G., and van Staa, T. P., Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database, J Am Coll Cardiol, vol. 66, pp. 1851-9, 2015.
C. J. van den Dries, van Doorn, S., Souverein, P., Pajouheshnia, R., Moons, K. G. M., Hoes, A. W., Geersing, G. J., and van den Ham, H. A., The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation, TH Open, vol. 4, pp. e417-e426, 2020.
H. A. van den Ham, Klungel, O. H., Leufkens, H. G., and van Staa, T. P., The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation, J Thromb Haemost, vol. 11, pp. 107-15, 2013.
Y. Zhang, Souverein, P. C., Gardarsdottir, H., van den Ham, H. A., van der Zee, A. H. Maitlan, and de Boer, A., Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population-based nested case-control study, Br J Clin Pharmacol, 2020.
E. M. Gieling, van den Ham, H. A., van Onzenoort, H., Bos, J., Kramers, C., de Boer, A., de Vries, F., and Burden, A. M., Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study, Br J Clin Pharmacol, vol. 83, pp. 1844-1859, 2017.
[Page last reviewed 4 February 2021]